Table 3.
Characteristic | Odds Ratio (95% CI) | P-value |
---|---|---|
Survival to 12 monthsb | ||
Post-operative cardiac surgery | 0.006 | |
No | Reference | |
Yes | 2.63 (1.32, 5.24) | |
Pre-arrest technology dependence | 0.033 | |
No | Reference | |
Yes | 0.18 (0.04, 0.87) | |
Survival to 12 months with VABS-II decreased ≤15 points from baselinec,d | ||
Open-chest cardiac massage | 0.009 | |
No | Reference | |
Yes | 3.09 (1.33, 7.18) | |
Gastrointestinal condition | 0.047 | |
No | Reference | |
Yes | 0.27 (0.07, 0.99) | |
Treatment Assigned | 0.065 | |
Hypothermia | 0.45 (0.19, 1.05) | |
Normothermia | Reference | |
Survival to 12 months with VABS-II ≥ 70c,e | ||
Gastrointestinal condition | 0.012 | |
No | Reference | |
Yes | 0.19 (0.05, 0.69) | |
Open-chest cardiac massage | 0.023 | |
No | Reference | |
Yes | 2.67 (1.15, 6.23) | |
Treatment Assigned | ||
Hypothermia | 0.49 (0.22, 1.10) | 0.084 |
Normothermia | Reference |
Models include variables available up to the time of randomization in the THAPCA-IH trial (THAPCA day 0).
Modeling is based on the 147 complete records in which all potential predictors and the outcome are non-missing.
VABS-II is Vineland Adaptive Behavior Scales, Second Edition.
Modeling is based on 145 complete records in which all potential predictors and the outcome are non-missing
Modeling is based on 128 complete records in which all potential predictors and the outcome are non-missing.